Oxidative Stress Promotes Transcriptional Up-regulation of Fyn in BCR-ABL1-expressing Cells

被引:35
作者
Gao, Yin [1 ]
Howard, Adrienne [1 ]
Ban, Kechen [1 ]
Chandra, Joya [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Childrens Canc Hosp MD Anderson, Dept Pediat Res, Unit 853, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
PROTEIN-TYROSINE KINASES; SRC-FAMILY KINASES; PHILADELPHIA-CHROMOSOME; ROS PRODUCTION; DNA-DAMAGE; GC BOXES; BCR/ABL; GENE; ACTIVATION; REGION;
D O I
10.1074/jbc.M804801200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Signaling initiated by the BCR-ABL1 kinase causes chronic myelogenous leukemia (CML). Recently, we reported that expression of Fyn, a Src kinase, is heightened in CML cells and patient specimens and confers in vitro and in vivo proliferative advantages. Fyn is regulated by redox, and because BCR-ABL1 raises intracellular oxidant levels, which have been implicated in CML progression, we explored the molecular regulation of Fyn. Here we identify the transcription factors that drive redox- and BCR-ABL1-dependent Fyn expression. Promoter deletion analysis in 293T, BaF3, BaF3-p210, and K562 cells identified the region essential for basal transcriptional activity. Mutation of Sp1 and Egr1 binding sites within the essential region diminished Fyn promoter activity and identified Egr1 as conferring redox sensitivity. Gel shift and chromatin immunoprecipitation assays confirmed the binding of Sp1 and Egr1 to the promoter fragments. Importantly, knockdown of Sp1 or Egr1 with small interference RNA or inhibition of Sp1 binding by mithramycin A repressed Fyn protein expression. Our work is the first to define transcription factors that are responsible for endogenous, oxidative stress-dependent and BCR-ABL1-dependent Fyn expression.
引用
收藏
页码:7114 / 7125
页数:12
相关论文
共 50 条
[1]   Fyn and JAK2 mediate Ras activation by reactive oxygen species [J].
Abe, J ;
Berk, BC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (30) :21003-21010
[2]   Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity:: implications for cancer therapy [J].
Albertini, V ;
Jain, A ;
Vignati, S ;
Napoli, S ;
Rinaldi, A ;
Kwee, I ;
Nur-e-Alam, M ;
Bergant, J ;
Bertoni, F ;
Carbone, GM ;
Rohr, J ;
Catapano, CV .
NUCLEIC ACIDS RESEARCH, 2006, 34 (06) :1721-1734
[3]   DEFECTIVE T-CELL RECEPTOR SIGNALING IN MICE LACKING THE THYMIC ISOFORM OF P59(FYN) [J].
APPLEBY, MW ;
GROSS, JA ;
COOKE, MP ;
LEVIN, SD ;
QIAN, X ;
PERLMUTTER, RM .
CELL, 1992, 70 (05) :751-763
[4]  
Arlinghaus Ralph, 2004, Cancer Treat Res, V119, P239
[5]   BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemia [J].
Ban, Kechen ;
Gao, Yin ;
Amin, Hesharn M. ;
Howard, Adrienne ;
Miller, Claudia ;
Lin, Quan ;
Leng, Xiaohong ;
Munsell, Mark ;
Bar-Eli, Menashe ;
Arlinghaus, Ralph B. ;
Chandra, Joya .
BLOOD, 2008, 111 (05) :2904-2908
[6]   Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma [J].
Berwanger, B ;
Hartmann, O ;
Bergmann, E ;
Bernard, S ;
Nielsen, D ;
Krause, M ;
Kartal, A ;
Flynn, D ;
Wiedemeyer, R ;
Schwab, M ;
Schäfer, H ;
Christiansen, H ;
Eilers, M .
CANCER CELL, 2002, 2 (05) :377-386
[7]  
BONHAM K, 1993, ONCOGENE, V8, P1973
[8]   Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes [J].
Chandra, J ;
Niemer, I ;
Gilbreath, J ;
Kliche, KO ;
Andreeff, M ;
Freireich, EJ ;
Keating, M ;
McConkey, DJ .
BLOOD, 1998, 92 (11) :4220-4229
[9]   High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2-dependent suppression of C/EBPα-driven myeloid differentiation [J].
Chang, Ii Suk ;
Santhanam, Ramasamy ;
Trotta, Rossana ;
Neviani, Paolo ;
Eiring, Anna M. ;
Briercheck, Edward ;
Ronchetti, Mattia ;
Roy, Denis C. ;
Calabretta, Bruno ;
Caligiuri, Michael A. ;
Perrotti, Danilo .
BLOOD, 2007, 110 (03) :994-1003
[10]  
COURTNEIDGE SA, 1993, DEVELOPMENT, P57